Aprepitant Capsule
Product Images NDC 68001-666

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Aprepitant (NDC 68001-666). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton- Aprepitant Capsules Usp 125mg 6s Pack (125mg 6caps)

Packaging label for Aprepitant Capsules, USP 125 mg, oral capsules by BluePoint Laboratories. The carton contains 6 capsules and is labeled for adults and pediatric patients 12 years and older. The label includes the NDC 68001-668-19, manufacturer information, storage instructions, and barcode. The design features a blue and white color scheme with the American Health Packaging logo.*

FDA Label Image

Carton Kit Pack (Aprepitant Capsules USP 125mg and 80mg 3 day kit pack)

Packaging label for Aprepitant Capsules, USP by BluePoint Laboratories showing 125 mg and 80 mg capsule strengths. The 3-day pack contains three capsules, with dosage details and manufacturer information for Glenmark Pharmaceuticals Limited, India. The label includes barcodes, storage conditions, and American Health Packaging branding.*

FDA Label Image

Caron (Aprepitant capsules USP 40mg 1s pack)

Packaging label for Aprepitant Capsules, USP 40 mg oral capsules. The carton shows the product name, strength (40 mg), dosage form (capsule), and quantity (1 capsule). The label includes a National Drug Code (NDC 68001-666-01), manufacturer details (Glenmark Pharmaceuticals Limited for BluePoint Laboratories), storage instructions, and a barcode. The design features a blue and green color scheme with the American Health Packaging logo.*

FDA Label Image

Carton Blister Card- Aprepitant Capsules Usp 80 mg 2s Pack (80mg 6cap)

Aprepitant Capsules, USP 80 mg oral capsules label from BluePoint Laboratories. The label indicates a 2-day pack containing 2 capsules, with dosage instructions for adults and pediatric patients 12 years and older. Manufacturer details include Glenmark Pharmaceuticals Limited, India. The label features product codes, storage instructions, and the American Health Packaging logo.*

FDA Label Image

Blister Foil- Aprepitant Capsules Usp 125mg 6s Pack (Aprepitant Capsules 125 mg 6s Pack Blister Foil)

Sheet of multiple identical labels for Aprepitant Capsule USP 125 mg. Each label includes the product name, strength, dosage form, and labeler BluePoint Laboratories. Labels display a barcode, lot number, and expiration date fields, along with manufacturing and packaging information. The layout is in black text on a white background with blue border lines.*

FDA Label Image

Blister Foil (Aprepitant Capsules USP 40mg 1s pack)

Labels for Aprepitant Capsule, USP 40 mg manufactured by Glenmark Pharmaceuticals Limited for BluePoint Laboratories. The label includes barcode, lot and expiration date fields, manufacturer and distributor information, and a contact phone number.*

FDA Label Image

Blister Foil (Aprepitant capsules USP 80mg 6s pack)

Label sheet for Aprepitant 80 mg capsules, USP, showing multiple panels designed for packaging. Each panel includes the drug name Aprepitant Capsule USP 80 mg, barcode, manufacturer information (BluePoint Laboratories), and typical labeling fields such as lot number and expiration date. The layout is for oral capsules intended for human prescription use.*

FDA Label Image

Carton- Aprepitant Capsules Usp 80mg 6s Pack (Apripitant Capsules 80 mg 6s Pack Carton)

Aprepitant Capsules, USP 80 mg oral capsule carton label for a 6-capsule package. The label indicates the drug is for adults and pediatric patients 12 years and older, is Rx only, and manufactured for BluePoint Laboratories. The label features barcodes and the American Health Packaging logo, with storage and dosage instructions included.*

FDA Label Image

Figure1 (Figure1)

This figure contains two Kaplan-Meier survival curves from Study 1 and Study 2 comparing the percent of patients over time (in hours up to 120) between an Aprepitant regimen and Standard Therapy. Both studies show higher patient retention percentages over time for the Aprepitant regimen compared to Standard Therapy.*

FDA Label Image

Figure2 (Figure2)

Bar charts comparing the percent of patients over chemotherapy cycles between the Aprepitant Regimen and Standard Therapy in two studies. Study 1 and Study 2 data include patient counts per chemotherapy cycle, showing higher response rates for Aprepitant in most cycles. The x-axis represents chemotherapy cycles 2 to 6, and the y-axis shows percent of patients from 0 to 100.*

FDA Label Image

Figure3 (Figure3)

A line graph comparing the percent of patients over time (in hours) for Aprepitant 40 mg and Ondansetron treatments. The x-axis represents hours from 0 to 48, and the y-axis shows the percent of patients from 0 to 100. The graph includes a legend indicating solid line for Aprepitant 40 mg (N=292) and dotted line for Ondansetron (N=279).*

FDA Label Image

Structure (Structure)

Chemical structure of Aprepitant, a pharmaceutical compound used in prescription drugs. The diagram shows molecular bonds and groups characteristic of Aprepitant's chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.